<?xml version='1.0' encoding='UTF-8'?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><id>https://front-matter.io/</id><title>Popular BioRxiv cancer-biology preprints posted in the last week</title><updated>2021-05-31T08:45:04.447131+00:00</updated><author><name>Martin Fenner</name><email>martin@front-matter.io</email></author><link href="https://front-matter.io" rel="alternate"/><link href="https://front-matter.io/cancer-biology/feed.xml" rel="self"/><generator uri="https://lkiesow.github.io/python-feedgen" version="0.9.0">python-feedgen</generator><entry><id>https://doi.org/10.1101/2021.05.26.443198</id><title>LMO2 is critical for early metastatic events in breast cancer (8 tweets)</title><updated>2021-05-31T08:45:04.447699+00:00</updated><author><name>Shaheen Sikandar</name></author><author><name>Jane Antony</name></author><author><name>Gunsagar S. Gulati</name></author><author><name>Angera H. Kuo</name></author><author><name>William Hai Dang Ho</name></author><author><name>Soumyashree Das</name></author><author><name>Chloé B. Steen</name></author><author><name>Thiago Almeida Pereira</name></author><author><name>Dalong Qian</name></author><author><name>Philip A. Beachy</name></author><author><name>Fredrick Dirbas</name></author><author><name>Kristy Red-Horse</name></author><author><name>Terence H. Rabbitts</name></author><author><name>Jean Paul Thiery</name></author><author><name>Aaron M. Newman</name></author><author><name>Michael F. Clarke</name></author><content>&lt;p&gt;Metastasis is responsible for the majority of breast cancer-related deaths, however identifying the cellular determinants of metastasis has remained challenging. Here, we identified a minority population of immature &lt;italic&gt;THY1&lt;/italic&gt;&lt;sup&gt;+&lt;/sup&gt;/&lt;italic&gt;VEGFA&lt;/italic&gt;&lt;sup&gt;+&lt;/sup&gt; tumor epithelial cells in human breast tumor biopsies that display angiogenic features and are marked by the expression of the oncogene, &lt;italic&gt;LMO2&lt;/italic&gt;. Higher abundance of &lt;italic&gt;LMO2&lt;/italic&gt;&lt;sup&gt;+&lt;/sup&gt; basal cells correlated with tumor endothelial content and predicted poor distant recurrence-free survival in patients. Using &lt;italic&gt;MMTV-PyMT/Lmo2&lt;/italic&gt;&lt;sup&gt;&lt;italic&gt;CreERT2&lt;/italic&gt;&lt;/sup&gt; mice, we demonstrated that &lt;italic&gt;Lmo2&lt;/italic&gt; lineage- traced cells have a higher propensity to metastasize. LMO2 knockdown in human breast tumors reduced lung metastasis by impairing intravasation, leading to a reduced frequency of circulating tumor cells. Mechanistically, we find that LMO2 binds to STAT3 and is required for STAT3 activation by TNFα and IL6. Collectively, our study identifies a population of metastasis-initiating cells with angiogenic features and establishes the LMO2-STAT3 signaling axis as a therapeutic target in breast cancer metastasis.&lt;/p&gt;&lt;sec&gt;&lt;title&gt;One sentence summary&lt;/title&gt;&lt;p&gt;LMO2 modulates STAT3 signaling in breast cancer metastasis.&lt;/p&gt;&lt;/sec&gt;</content><link href="https://doi.org/10.1101/2021.05.26.443198" rel="alternate" title="LMO2 is critical for early metastatic events in breast cancer (8 tweets)"/><category term="Cancer Biology"/><published>2021-05-26T00:00:00+00:00</published></entry></feed>